logo
logo

NovaSight Closes $8M Series A Financing in Quest to Combat Vision Disorders Worldwide

Jul 13, 2020about 5 years ago

Amount Raised

$8 Million

Round Type

series a

Description

  NovaSight, the Israeli start-up specializing in ground-breaking vision care solutions based on AI and eye tracking technology announced today that it has finalized its round A financing totaling $8M. The round was led by Rimonci Capital and joined by world leading strategic investors from both pharmaceutical and medical device industries. Prior to this round the company raised $8M for a total of $16M.

Company Information

Company

Nova Sight:

About

NovaSight is an Israeli start-up that focuses on bringing pediatric vision care into the digital age. Founded in 2016, NovaSight has experienced rapid growth by delivering complete end-to-end AI and eye tracking-based solutions for accurate screening and treatment of early vision disorders.